Medical Developments International Limited
MVP
주식 순위
#27327
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
주가
$0.28564034
마지막 동기화: 2026-10-16
시가총액
$32.18M
변동 (1일)
0.62%
변동 (1년)
-10.90%
국가
AU
거래 Medical Developments International Limited (MVP)
카테고리
Healthcare
의 시가총액 Medical Developments International Limited(MVP)
시가총액: $32.18M
October 2026 기준으로 Medical Developments International Limited의 시가총액은 $32.18M입니다. 이는 당사 데이터에 따르면 Medical Developments International Limited이 세계에서 27327th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2020부터 2026까지 Medical Developments International Limited의 시가총액 기록
